Page last updated: 2024-08-26

lopinavir and Preterm Birth

lopinavir has been researched along with Preterm Birth in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK1
Cohan, D; Conroy, AL; Dorsey, G; Gamble, JL; Havlir, DV; Kain, KC; Kamya, MR; McDonald, CR; Natureeba, P; Olwoch, P1
Bailey, H; Favarato, G; Peters, H; Taylor, GP; Thorne, C; Tookey, PA; Townsend, CL1
Barr, E; Chadwick, EG; Currier, JS; Hernandez-Diaz, S; Hoffman, RM; Huo, Y; Patel, K; Rough, K; Seage, GR; Shapiro, DE; Williams, PL1
Achan, J; Ades, V; Charlebois, ED; Clark, TD; Cohan, D; Havlir, DV; Kamya, MR; Koss, CA; Luwedde, F; Mwesigwa, J; Natureeba, P; Nzarubara, B; Plenty, A; Ruel, T1
Chen, H; Chen, J; Guo, C; Huang, X; Li, N; Li, Z; Wu, H; Xu, Y; Yang, Q; Zhang, T1
Anderson, J; Barbour, A; Conway, K; Dermont, S; deRuiter, A; Dwyer, E; Flanagan, S; Hawkins, D; Hay, P; McKendry, A; Mulka, L; Perry, ME; Rodgers, M; Roedling, S; Sabin, CA; Sarner, L; Shah, R; Stevenson, J; Taylor, GP; Williams, E; Wood, C1

Reviews

1 review(s) available for lopinavir and Preterm Birth

ArticleYear
Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials.
    Scientific reports, 2015, Feb-23, Volume: 5

    Topics: Adult; Anti-HIV Agents; Birth Weight; Cholesterol; Databases, Factual; Female; HIV Infections; Humans; Infant, Newborn; Lopinavir; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Ritonavir; Treatment Outcome

2015

Trials

2 trial(s) available for lopinavir and Preterm Birth

ArticleYear
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    AIDS (London, England), 2019, 12-01, Volume: 33, Issue:15

    Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine

2019
Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2014, Oct-01, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Infant, Newborn; Lopinavir; Male; Pregnancy; Premature Birth; Risk Factors; Ritonavir; Uganda; Young Adult

2014

Other Studies

4 other study(ies) available for lopinavir and Preterm Birth

ArticleYear
Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
    American journal of obstetrics and gynecology, 2017, Volume: 217, Issue:6

    Topics: Adult; Alkynes; Angiopoietin-1; Angiopoietin-2; Anti-HIV Agents; Benzoxazines; Biomarkers; Cyclopropanes; Drug Combinations; Endoglin; Female; HIV Infections; Humans; Infant, Newborn; Infant, Small for Gestational Age; Lopinavir; Neovascularization, Physiologic; Placenta Growth Factor; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Ritonavir; Stillbirth; Uganda; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2017
Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS (London, England), 2018, Jan-14, Volume: 32, Issue:2

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Ireland; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Risk Assessment; Ritonavir; United Kingdom

2018
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    The New England journal of medicine, 2018, 04-26, Volume: 378, Issue:17

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Disease Transmission, Infectious; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Zidovudine

2018
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates.
    HIV medicine, 2016, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Atazanavir Sulfate; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infant, Newborn; Lopinavir; Middle Aged; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies; Ritonavir; Treatment Outcome; Viral Load; Young Adult

2016